Internal Medicine, Rheumatology · Statesville, NC
NPI
1649270190
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
293 Old Mocksville Rd
Statesville, NC, 28625
Phone (704) 872-8711
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.9M
237,595 services
Medicare patients, 2024
787
Average age 72
Drug cost, 2024
$4.6M
6,920 prescriptions
Company payments, 2025
$7,138
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bob Wodecki was code J3262 (injection, tocilizumab, 1 mg), 102,577 times for 28 patients. In total Bob Wodecki billed 237,595 services in 140 codes, and Medicare paid $2.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 102,577 | 28 | $4.69 | $481K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 30,475 | 32 | $8.99 | $274K |
| J7328 Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 19,007 | 31 | $0.37 | $7,112 |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 17,202 | 32 | $33.80 | $581K |
| J9312 Injection, rituximab, 10 mg | Office | 8,754 | 26 | $59.81 | $524K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 5,970 | 20 | $24.64 | $147K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 5,962 | 114 | $0.10 | $606 |
| J0897 Injection, denosumab, 1 mg | Office | 5,102 | 55 | $20.33 | $104K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 2,338 | 41 | $0.23 | $533 |
| 99214 Office E&M - Established | Office | 1,390 | 602 | $87.12 | $121K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,331 | 166 | $0.73 | $965 |
| 85025 Blood Count | Office | 1,004 | 472 | $7.58 | $7,609 |
| 85651 Clinical Chemistry | Office | 925 | 438 | $4.16 | $3,848 |
| J1201 Injection, cetirizine hydrochloride, 0.5 mg | Office | 702 | 25 | $11.72 | $8,229 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 614 | 79 | $0.09 | $53.32 |
By year: 2022 $4.4M for 228,502 services; 2023 $5.4M for 262,519 services; 2024 $2.9M for 237,595 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,004 | 472 | $7.58 | $7,609 |
| 85651 Clinical Chemistry | 925 | 438 | $4.16 | $3,848 |
| 86235 Immunoassay | 546 | 73 | $17.24 | $9,414 |
| 36415 Venipuncture Blood Collection | 300 | 132 | $8.65 | $2,595 |
| 82306 Clinical Chemistry | 228 | 182 | $28.89 | $6,587 |
| 83516 Immunoassay | 167 | 82 | $11.19 | $1,869 |
| 86481 Immunoassay | 160 | 159 | $98.00 | $16K |
| 86225 Immunoassay | 78 | 73 | $13.22 | $1,031 |
| 86226 Immunoassay | 78 | 73 | $11.65 | $908 |
| 86038 Immunoassay | 77 | 75 | $11.76 | $906 |
Medicare prescription drug claims, 2024
In 2024, the drug Bob Wodecki prescribed most often to Medicare patients was Meloxicam, with 859 prescriptions and refills. In total Bob Wodecki wrote 6,920 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Meloxicam Generic | 859 | 1,292 | 205 | $2,712 |
| Hydroxychloroquine Sulfate Generic | 676 | 1,214 | 178 | $20K |
| Methotrexate Methotrexate Sodium | 621 | 1,103 | 159 | $8,429 |
| Prednisone Generic | 617 | 787 | 136 | $3,050 |
| Celecoxib Generic | 324 | 532 | 87 | $7,944 |
| Gabapentin Generic | 290 | 337 | 78 | $2,355 |
| Tizanidine Hcl Generic | 260 | 460 | 77 | $1,773 |
| Tramadol Hcl Generic | 250 | 250 | 90 | $2,124 |
| Leflunomide Generic | 182 | 326 | 52 | $6,231 |
| Allopurinol Generic | 165 | 314 | 50 | $1,045 |
| Colchicine Generic | 164 | 236 | 52 | $4,781 |
| Pregabalin Generic | 152 | 162 | 31 | $2,030 |
| Cyclobenzaprine Hcl Generic | 147 | 199 | 28 | $880 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 134 | 368 | 54 | $2,027 |
| Folic Acid Generic | 125 | 301 | 39 | $1,019 |
Brand drugs: 714 claims; generic drugs: 6,195 claims; opioid claims: 404.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bob Wodecki $7,138 ($7,138 in general payments such as food, travel and fees) from 29 companies. The largest payer was Janssen Biotech, Inc. with $2,887.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 28 | $2,887 |
| Amgen Inc. AMGN | 56 | $697 |
| Abbvie Inc. ABBV | 33 | $575 |
| Pfizer Inc. PFE | 19 | $310 |
| ANI Pharmaceuticals, Inc. ANIP | 16 | $293 |
| Novartis Pharmaceuticals Corporation NVS | 20 | $279 |
| Mallinckrodt Hospital Products Inc. | 8 | $250 |
| Radius Health, Inc. | 10 | $223 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $221 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $209 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.